These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3861122)

  • 1. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
    Crawley JN
    Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
    Crawley JN; Stivers JA; Blumstein LK; Paul SM
    J Neurosci; 1985 Aug; 5(8):1972-83. PubMed ID: 4040554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine microinjection into the nucleus accumbens: correlation between metabolism and behavior.
    Kalivas PW; Miller JS
    Biochem Pharmacol; 1985 Jan; 34(2):284-6. PubMed ID: 3966931
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of sulpiride injected into the dorsal striatum and the nucleus accumbens on dopamine-mediated oral stereotypy and hyperlocomotion in rats.
    Koshikawa N; Aoki S; Imai E; Kobayashi M
    J Nihon Univ Sch Dent; 1986 Jun; 28(2):109-16. PubMed ID: 3463674
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN; Hommer DW; Skirboll LR
    Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of cholecystokinin and dopamine in the nucleus accumbens.
    Wang RY; White FJ; Voigt MM
    Ann N Y Acad Sci; 1985; 448():352-60. PubMed ID: 2862829
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations of accumbens neuronal activity in freely moving rats following methamphetamine.
    Fukuzako H; Nagatomo I; Nomaguchi M; Takenouchi K; Matsumoto K
    Jpn J Psychiatry Neurol; 1988 Jun; 42(2):331-5. PubMed ID: 2853805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
    Katsuura G; Itoh S; Hsiao S
    Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gamma-Endorphin and N alpha-acetyl-gamma-endorphin interfere with distinct dopaminergic systems in the nucleus accumbens via opioid and non-opioid mechanisms.
    van Ree JM; Gaffori O; Kiraly I
    Life Sci; 1984 Apr; 34(14):1317-24. PubMed ID: 6200747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
    Vance MA; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the sensitivity of dopamine receptors in the nucleus accumbens and in the striatum induced by chronic ethanol administration.
    Liljequist S
    Acta Pharmacol Toxicol (Copenh); 1978 Jul; 43(1):19-28. PubMed ID: 568374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R; Cools AR; Ogren SO
    Acta Physiol Scand; 1990 Mar; 138(3):423-4. PubMed ID: 2158210
    [No Abstract]   [Full Text] [Related]  

  • 19. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
    Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ
    Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effects of D-amphetamine on spontaneous neuronal activity in the neostriatum and nucleus accumbens.
    Rebec GV; Zimmerman KS
    Brain Res; 1980 Nov; 201(2):485-91. PubMed ID: 7191347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.